Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Collaborate
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
About
About
EQOH
Careers
Contact Us
EMJ Gold
search
Join
FREE
You must accept all conditions before being able to view the post
Continue
EUR
USA
EUR
USA
Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Collaborate
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
About
About
EQOH
Careers
Contact Us
EMJ Gold
Join
FREE
Edition
European
US
Microbiology & Infectious Diseases
Filter
Journals
About
Congress reviews
Abstracts
Articles
Podcasts
Videos & Webinars
News
Infographics
Submit A Paper
Annual Lenacapavir Injection Could Revolutionise HIV PrEP
March 2025
New findings highlight the potential of once-yearly intramuscular lenacapavir for PrEP, offering a long-acting alternative that could reduce barriers to HIV prevention.
Read more
27 Jan 2025
CROSS Score Predicts COVID-19 ICU Admission Risk
The CROSS score has been developed to accurately predict the risk of intensive care unit admission for patients with COVID-19 who present at the emergency room.
25 Jan 2025
HDV Superinfection Risk Persists in People with HBV–HIV Coinfection
A decade-long study has shed light on the risks of hepatitis D virus superinfection in people with HIV co-infected with hepatitis B virus.
23 Jan 2025
15% of Children Aged Under 3 Years Receive Invalid Vaccine Doses
Research reveals that 15% of children aged 0–35 months in the USA received at least one invalid vaccine dose between 2011–2020.
21 Jan 2025
Increased ME/CFS Risk in Adults Post-COVID-19
The ongoing RECOVER-Adult study reveals that myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) develops significantly more frequently following SARS-CoV-2 infection.
19 Jan 2025
Procalcitonin Guidance Fails to Shorten Antibiotic Use in Children
Using a procalcitonin-guided algorithm does not significantly reduce duration of IV antibiotic treatment in children with bacterial infections.
17 Jan 2025
New Antibodies Offer Hope for Malaria Vaccine Complementation
A recent study has identified a previously unknown antibody target on the Plasmodium falciparum sporozoite surface.
15 Jan 2025
Gut Microbiome Signatures of Different Diets Revealed
A new multinational study has uncovered how omnivore, vegetarian, and vegan diets affect the human gut microbiome
13 Jan 2025
HMPV Cases Surge in Northern Hemisphere
Human metapneumovirus (hMPV) is making headlines as one of the key respiratory pathogens driving a surge in acute respiratory infections.
Loading posts...
« Previous
1
…
3
4
5
6
7
…
22
Next »